Clinical Trial Update: MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) [Phase 2]

View source ↗

Summary

The MINIMA-2 Phase 2 trial investigating microdoses of ranibizumab for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Especialistas en Retina Medica y Quirurgica Grupo de Investigacion | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED